Joy Christine Burk, MD | |
410 4th St Ste J, Alva, OK 73717-2363 | |
(580) 430-3333 | |
(580) 430-3305 |
Full Name | Joy Christine Burk |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 410 4th St Ste J, Alva, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063444396 | NPI | - | NPPES |
1063444396 | Medicaid | MT | |
10000292 | Other | OK | OBNDD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 8796 (Montana) | Secondary |
208000000X | Pediatrics | 18958 (Oklahoma) | Primary |
Entity Name | Alva Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679684682 PECOS PAC ID: 5597755306 Enrollment ID: O20040514000014 |
News Archive
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics - 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.
The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects.
A research team from the Department of Computer Science and Engineering and the Electronics-Inspired Interdisciplinary Research Institute at Toyohashi University of Technology has indicated that the relationship between attentional states in response to pictures and sounds and the emotions elicited by them may be different in visual perception and auditory perception.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Joy Christine Burk, MD 410 4th St Ste J, Alva, OK 73717-2363 Ph: (580) 433-3333 | Joy Christine Burk, MD 410 4th St Ste J, Alva, OK 73717-2363 Ph: (580) 430-3333 |
News Archive
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics - 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.
The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects.
A research team from the Department of Computer Science and Engineering and the Electronics-Inspired Interdisciplinary Research Institute at Toyohashi University of Technology has indicated that the relationship between attentional states in response to pictures and sounds and the emotions elicited by them may be different in visual perception and auditory perception.
› Verified 8 days ago